A safe and effective way to treat glaucoma is a primary treatment known as Selective Laser Trabeculoplasty (SLT).

This treatment can reduce intraocular pressure (IOP) in a single procedure and reduces or eliminates the need for contemporary glaucoma medications.

Selective Laser Trabeculoplasty allows specific cells to be targeted, using pulses of low energy laser light to target melanin containing cells in a network of channels known as the trabecular meshwork.

The laser treatment leaves untreated areas of the trabecular meshwork intact, minimising trauma to the Schlemm's canal, which drains the fluid away from the trabecular meshwork. The selective targeting of the pigmented trabecular meshwork cells is the main advantage of SLT over traditional argon laser techniques.

The avoidance of any thermal damage to non pigmented cells or other local structures, such as the scleral beams of meshwork tissue allows the treatment to be safely repeated several times.

Argon Laser Trabeculectomy

alt :

If you have been affected by any of the symptoms mentioned above, please don't hesitate to give us a call.

We have a team of experts on stand-by who are ready to take your call at our Manchester (0161 907 2685) Clinic or our Blackpool (01253 308 031) Clinic.